Home / Tin tức / Thông tin Y khoa / Cochrane Nhi Khoa / Long-term response to deferiprone therapy in Asian Indians

Long-term response to deferiprone therapy in Asian Indians

Ann Hematol. 2010 Feb;89(2):135-40. Epub 2009 Aug 5.

Panigrahi IMarwaha RKDas RR.

Hemato-Oncology & Genetics Units, Department of Pediatrics, Advanced Pediatrics Centre (APC), Post-Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India. inupan@yahoo.com

Deferiprone (L1) has been used in several countries for iron chelation therapy for over one decade. Long-term results on the drug are lacking. In the present study, data of 110 patients on deferiprone (L1) for up to 17 years were analyzed. On a mean L1 dose of 70.2 mg/kg/day (range 44-100), serum ferritin level showed a very steady decrease with time from an initial mean (+/-SD) of 3,033.61 +/- 1,468.04 ng/ml to final of 1,665.08 +/- 949.93 ng/ml after a mean (+/-SD) of 6.1 +/- 3.8 years. In total, 13 patients discontinued L1 therapy. Major complications of L1 requiring permanent discontinuation of treatment included arthropathy (n = 8, 7.2%) and neutropenia/agranulocytosis (n = 5, 4.5%). Lesser complications permitting continued L1 treatment included transient mild leucopenia or thrombocytopenia (n = 3) and gastrointestinal problems (n = 5). There were a total of three deaths attributed to agranulocytosis. Although the complications associated with L1 treatment are significant and require close monitoring, they do not preclude effective long-term therapy in the vast majority of patients. A longer duration of therapy is required for effective response in chronically iron-overloaded patients. Further well-controlled prospective studies of L1 are required to identify factors affecting individual response to therapy.

Advertisements

Check Also

Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003124.

Duijvestijn YCMourdi NSmucny JPons GChalumeau M.

Source: Department of Paediatrics (119), Medical Centre Alkmaar, Wilhelminalaan 12, Alkmaar, Netherlands, 1815 JD. yvonneduijvestijn@xs4all.nl

Leave a Reply

Your email address will not be published. Required fields are marked *